These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

666 related items for PubMed ID: 26801828

  • 1. Antidepressant-like effect of cannabidiol injection into the ventral medial prefrontal cortex-Possible involvement of 5-HT1A and CB1 receptors.
    Sartim AG, Guimarães FS, Joca SR.
    Behav Brain Res; 2016 Apr 15; 303():218-27. PubMed ID: 26801828
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cannabidiol in the prelimbic cortex modulates the comorbid condition between the chronic neuropathic pain and depression-like behaviour in rats: The role of medial prefrontal cortex 5-HT1A and CB1 receptors.
    Malvestio RB, Medeiros P, Negrini-Ferrari SE, Oliveira-Silva M, Medeiros AC, Padovan CM, Luongo L, Maione S, Coimbra NC, de Freitas RL.
    Brain Res Bull; 2021 Sep 15; 174():323-338. PubMed ID: 34192579
    [Abstract] [Full Text] [Related]

  • 4. Cannabidiol attenuates aggressive behavior induced by social isolation in mice: Involvement of 5-HT1A and CB1 receptors.
    Hartmann A, Lisboa SF, Sonego AB, Coutinho D, Gomes FV, Guimarães FS.
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Aug 30; 94():109637. PubMed ID: 31054943
    [Abstract] [Full Text] [Related]

  • 5. Effects of intra-prelimbic prefrontal cortex injection of cannabidiol on anxiety-like behavior: involvement of 5HT1A receptors and previous stressful experience.
    Fogaça MV, Reis FM, Campos AC, Guimarães FS.
    Eur Neuropsychopharmacol; 2014 Mar 30; 24(3):410-9. PubMed ID: 24321837
    [Abstract] [Full Text] [Related]

  • 6. Motor effects of the non-psychotropic phytocannabinoid cannabidiol that are mediated by 5-HT1A receptors.
    Espejo-Porras F, Fernández-Ruiz J, Pertwee RG, Mechoulam R, García C.
    Neuropharmacology; 2013 Dec 30; 75():155-63. PubMed ID: 23924692
    [Abstract] [Full Text] [Related]

  • 7. Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT/glutamate neurotransmission: role of 5-HT1A receptors.
    Linge R, Jiménez-Sánchez L, Campa L, Pilar-Cuéllar F, Vidal R, Pazos A, Adell A, Díaz Á.
    Neuropharmacology; 2016 Apr 30; 103():16-26. PubMed ID: 26711860
    [Abstract] [Full Text] [Related]

  • 8. Cannabidiol inhibits the hyperphagia induced by cannabinoid-1 or serotonin-1A receptor agonists.
    Scopinho AA, Guimarães FS, Corrêa FM, Resstel LB.
    Pharmacol Biochem Behav; 2011 Apr 30; 98(2):268-72. PubMed ID: 21238476
    [Abstract] [Full Text] [Related]

  • 9. Cannabinoid CB1 receptors in the medial prefrontal cortex modulate the expression of contextual fear conditioning.
    Lisboa SF, Reis DG, da Silva AL, Corrêa FM, Guimarães FS, Resstel LB.
    Int J Neuropsychopharmacol; 2010 Oct 30; 13(9):1163-73. PubMed ID: 20587131
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cannabidiol induces antidepressant and anxiolytic-like effects in experimental type-1 diabetic animals by multiple sites of action.
    Chaves YC, Genaro K, Crippa JA, da Cunha JM, Zanoveli JM.
    Metab Brain Dis; 2021 Apr 30; 36(4):639-652. PubMed ID: 33464458
    [Abstract] [Full Text] [Related]

  • 12. Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats.
    Campos AC, Guimarães FS.
    Psychopharmacology (Berl); 2008 Aug 30; 199(2):223-30. PubMed ID: 18446323
    [Abstract] [Full Text] [Related]

  • 13. Involvement of CB1 and TRPV1 receptors located in the ventral medial prefrontal cortex in the modulation of stress coping behavior.
    Sartim AG, Moreira FA, Joca SRL.
    Neuroscience; 2017 Jan 06; 340():126-134. PubMed ID: 27771531
    [Abstract] [Full Text] [Related]

  • 14. Cannabidiol, a non-psychotropic component of cannabis, attenuates vomiting and nausea-like behaviour via indirect agonism of 5-HT(1A) somatodendritic autoreceptors in the dorsal raphe nucleus.
    Rock EM, Bolognini D, Limebeer CL, Cascio MG, Anavi-Goffer S, Fletcher PJ, Mechoulam R, Pertwee RG, Parker LA.
    Br J Pharmacol; 2012 Apr 06; 165(8):2620-34. PubMed ID: 21827451
    [Abstract] [Full Text] [Related]

  • 15. A dual inhibitor of FAAH and TRPV1 channels shows dose-dependent effect on depression-like behaviour in rats.
    Kirkedal C, Wegener G, Moreira F, Joca SRL, Liebenberg N.
    Acta Neuropsychiatr; 2017 Dec 06; 29(6):324-329. PubMed ID: 27938441
    [Abstract] [Full Text] [Related]

  • 16. Cannabidiol blocks long-lasting behavioral consequences of predator threat stress: possible involvement of 5HT1A receptors.
    Campos AC, Ferreira FR, Guimarães FS.
    J Psychiatr Res; 2012 Nov 06; 46(11):1501-10. PubMed ID: 22979992
    [Abstract] [Full Text] [Related]

  • 17. Participation of the 5-HT1A receptor in the antidepressant-like effect of estrogens in the forced swimming test.
    Estrada-Camarena E, Fernández-Guasti A, López-Rubalcava C.
    Neuropsychopharmacology; 2006 Feb 06; 31(2):247-55. PubMed ID: 16012533
    [Abstract] [Full Text] [Related]

  • 18. The anxiolytic effects of cannabidiol in chronically stressed mice are mediated by the endocannabinoid system: Role of neurogenesis and dendritic remodeling.
    Fogaça MV, Campos AC, Coelho LD, Duman RS, Guimarães FS.
    Neuropharmacology; 2018 Jun 06; 135():22-33. PubMed ID: 29510186
    [Abstract] [Full Text] [Related]

  • 19. Altered expression of 5-HT1A receptors in adult rats induced by neonatal treatment with clomipramine.
    Limón-Morales O, Soria-Fregozo C, Arteaga-Silva M, Vázquez-Palacios G, Bonilla-Jaime H.
    Physiol Behav; 2014 Jan 30; 124():37-44. PubMed ID: 24211235
    [Abstract] [Full Text] [Related]

  • 20. Dissociable contribution of 5-HT1A and 5-HT2A receptors in the medial prefrontal cortex to different aspects of executive control such as impulsivity and compulsive perseveration in rats.
    Carli M, Baviera M, Invernizzi RW, Balducci C.
    Neuropsychopharmacology; 2006 Apr 30; 31(4):757-67. PubMed ID: 16192987
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.